22 Biopharma Companies Partner and Launch First-of-its-kind Global Initiative to Address Rise of Non-Communicable Diseases Global, multi-stakeholder collaboration, called Access Accelerated, to be delivered in partnership with World Bank Group and Union for International Cancer Control (UICC) Initial three-year commitment will catalyze, develop, measure and replicate sustainable programs in low and lower-middle income countries...
Read moreBiopharmaceutical companies are committed to enhancing public health through responsible sharing of clinical trial data in a manner that is consistent with the following principles: Safeguarding the privacy of patients, respecting the integrity of national regulatory systems, and maintaining incentives for investment in biomedical research.
Read moreGeneva, 2 December 2016 – On 29 November 2016, Thomas B. Cueni was appointed Director General of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), the organization representing biopharmaceutical companies as well as national and regional associations across the world. He will succeed Eduardo Pisani who recently announced his departure after seven years...
Read moreIan C. Read, Chairman of the Board and Chief Executive Officer, Pfizer, takes over as President of IFPMA from Dr Stefan Oschmann, Chairman of the Executive Board and CEO, Merck KGaA, Darmstadt, Germany. New President to foster innovative health ecosystems and expand partnerships and focus on people/patient-centric and systemic approaches to ensure health through the...
Read moreCommitted to a Healthier Future 2016 IFPMA General Assembly 30 November 2016 Welcome remarks by Eduardo Pisani Director General IFPMA Good morning and welcome to the 28th IFPMA assembly. The biopharmaceutical industry is committed to a healthier future for the people around the world, and this is the theme we have chosen for our assembly....
Read moreCommitted to a Healthier Future 2016 IFPMA General Assembly 30 November 2016 Opening address by Dr. Stefan Oschmann President, IFPMA, Chairman of the Executive Board and CEO, Merck KGaA, Darmstadt, Germany Thank you, Eduardo for your kind introduction. Good morning Partners, Colleagues, Ladies and Gentlemen. I’d like to warmly welcome all of you to the...
Read moreCommitted to a Healthier Future 2016 IFPMA General Assembly 30 November 2016 Concluding remarks by Ian Read Incoming President, IFPMA, Chairman of the Board and Chief Executive Officer, Pfizer Good afternoon. I am delighted to be with you this afternoon. I want to begin by thanking Stefan Oschmann for his outstanding leadership over the past...
Read morePlease click on the image above for this must watch video! It’s universally agreed that patients should be able to expect medicines and vaccines to be available when they need them. Yet in some parts of the world, access to high-quality, safe, and efficient treatments can be a cumbersome/awkward walk through many, sometimes fatal,...
Read moreSimplifying regulatory complexity for better products to be available to patients faster.
Read more